Friday, October 1
|
|
8:00 am - 5:00 pm |
Workshop on Monoclonal Antibodies in Cancer
Separate registration required. For more information, including the schedule, please click here.
|
|
8:00 am - 5:00 pm |
Primer on Tumor Immunology and Biological Therapy of Cancer
Separate registration required. For more information, including the schedule, please click here.
|
|
|
Saturday, October 2
|
|
7:50 am - 8:00 am |
President's Welcome
Bernard A. Fox, PhD - Earle A. Chiles Research Institute |
|
8:00 am - 8:45 am |
Richard V. Smalley, MD Memorial Lectureship
James P. Allison, PhD - Memorial Sloan-Kettering Cancer Center |
|
8:45 am - 11:30 am |
Plenary Session: Dendritic Cells and Cancer
Co-Chairs: Carl G. Figdor, PhD - Nijmegen Centre for Molecular Life Sciences
Pawel Kalinski, MD, PhD - University of Pittsburgh Cancer Institute
Invited
Speakers: Carl G. Figdor, PhD - Nijmegen Centre for Molecular Life Sciences
Pawel Kalinski, MD, PhD - University of Pittsburgh Cancer Institute
David L. Urdal, PhD - Dendreon Corporation
|
|
11:30 am - 1:30 pm |
Lunch with Poster Viewing and Exhibits |
|
1:30 pm - 3:00 pm |
Concurrent Session I: Targeted Therapeutics and Immunotherapy
Co-Chairs Mary L. Disis, MD - University of Washington
& Speakers: Keiran S. Smalley, PhD - H. Lee Moffitt Cancer & Research Center |
|
1:30 pm - 3:00 pm |
Concurrent Session II: Innate / Adaptive Immune Interplay in Cancer
Co-Chairs Vincenzo Cerundolo, MD, PhD - University of Oxford - Inst. of Molec. Medicine
& Speakers: Laurence Zitvogel, MD, PhD - Institute Gustave Roussy |
|
3:00 pm - 3:15 pm |
Break |
|
3:15 pm - 5:15 pm |
Plenary Session: Clinical Trial Endpoints
Co-Chairs: F. Stephen Hodi, MD - Dana-Farber Cancer Institute
Vernon K. Sondak, MD - H. Lee Moffitt Cancer & Research Center
Invited
Speakers: F. Stephen Hodi, MD - Dana-Farber Cancer Institute
Lawrence Fong, MD - University of California - San Francisco
Vernon K. Sondak, MD - H. Lee Moffitt Cancer & Research Center
Annick Van den Abbeele, MD - Dana-Farber Cancer Institute
|
|
5:15 pm - 5:45 pm |
Special Program Announcement |
|
5:45 pm - 6:15 pm |
iSBTc Membership Business Meeting
|
|
6:15 pm - 8:00 pm |
Poster Reception |
|
|
|
Sunday, October 3
|
8:00 am - 8:45 am
|
Keynote Address
Cornelius J.M. Melief, MD, PhD - Leiden University Medical Center
|
|
8:45 am - 11:30 am |
Plenary Session: Vaccine Combinations
Co-Chairs: Pierre Coulie, MD, PhD - de Duve Institute and University of Louvain
Victor H. Engelhard, PhD - University of Virginia School of Medicine
Invited
Speakers: Pierre Coulie, MD, PhD - de Duve Institute and University of Louvain
Victor H. Engelhard, PhD - University of Virginia School of Medicine
Jedd D. Wolchok, MD, PhD - Memorial Sloan-Kettering Cancer Center |
|
11:30 am - 1:30 pm |
Lunch with Poster Viewing and Exhibits |
|
1:30 pm - 2:50 pm |
iSBTc Presidential Session
Chair: Bernard A. Fox, PhD - Earle A. Chiles Research Institute |
|
2:50 pm - 3:15 pm |
Break |
|
3:15 pm - 4:45 pm |
Concurrent Session I: Countering Negative Regulation
Co-Chairs Pierre van der Bruggen, PhD - Ludwig Institute for Cancer Research
& Speakers: Weiping Zou, MD, PhD - University of Michigan
|
|
3:15 pm - 4:45 pm |
Concurrent Session II: Immune Cell Trafficking to Tumor Microenvironment
Co-Chairs Thomas F. Gajewski, MD, PhD - University of Chicago
& Speakers: Elizabeth M. Jaffee, MD - Johns Hopkins University
|
|
5:00 pm - 5:30 pm |
Update: 2009 iSBTc-FDA-NCI Workshop on Prognostic and Predictive Immunologic Biomarkers in Cancer
Lisa H. Butterfield, PhD - University of Pittsburgh |
|
5:30 pm - 6:00 pm |
Session: Topic to be announced |
|
7:00 pm - 10:00 pm |
25th Anniversary & Awards Reception
To be held at the Smithsonian National Museum of Natural History
|
|
|
|
Monday, October 4
|
|
8:00 am - 10:15 am |
Plenary Session: Adoptive T Cell Transfer: The Next Wave
Co-Chairs: Patrick Hwu, MD - MD Anderson Center Center
Ton Schumacher, PhD - Netherlands Cancer Institute
Invited
Speakers: Malcolm K. Brenner, MD, PhD - Baylor College of Medicine
Patrick Hwu, MD - MD Anderson Center Center
Ton Schumacher, PhD - Netherlands Cancer Institute |
|
10:15 am - 10:30 am |
Break |
|
10:30 am - 12:00 pm |
Hot Topic Symposium: CTLA-4 Blockade as a Cancer Therapeutic: How Do We Build on a Successful Foundation?
For more information, please click here.
|
